Durham, N.C. – FHI 360 was selected by USAID as the prime implementing partner for the STRengthening Infectious disease DEtection Systems (STRIDES) Activity, which aims to support partner countries as they strengthen their detection, surveillance, data collection and analytical capacities to prevent and mitigate the occurrence and severity of epidemics, pandemics and novel infectious disease threats.
“For countries to more effectively prevent, detect and respond to emerging disease threats, we must prioritize robust national and global surveillance and diagnostics infrastructure,” says Becca Price, FHI 360’s project director for the STRIDES Activity. “This requires reliable, safe and secure laboratory and disease surveillance systems, coupled with effective data management and reporting platforms. Together with our partners, we can help strengthen systems to ensure that pathogens do not spread widely and rapidly.”
Anchored in biosafety and biosecurity technical assistance and oversight, the STRIDES Activity will:
- Enhance the capacity of national and subnational human and animal health infectious disease detection and surveillance systems.
- Develop and strengthen data collection, analysis and reporting to support actionable decision making and to guide response efforts.
- Provide targeted detection and surveillance technical assistance during outbreaks.
FHI 360’s consortium for STRIDES consists of three major subcontractors, PATH, Black & Veatch and Panagora Group, and six regional-based public health organizations, Amref Health Africa, African Society for Laboratory Medicine, Prisma, Africa One Health University Network, Southeast Asia One Health University and The Eastern Mediterranean Public Health Network.
For more on FHI 360’s work in global health, visit: fhi360.org/technical-areas/health/.
Media relations contact:
Jennifer Garcia
FHI 360 Media Relations Manager
jgarcia@fhi360.org
